Proteinaceous Regulators and Inhibitors of Protein Tyrosine Phosphatases
AbstractProper control of the phosphotyrosine content in signal transduction proteins is essential for normal cell behavior and is lost in many pathologies. Attempts to normalize aberrant tyrosine phosphorylation levels in disease states currently involve either the application of small compounds that inhibit tyrosine kinases (TKs) or the addition of growth factors or their mimetics to boost receptor-type TK activity. Therapies that target the TK enzymatic counterparts, the multi-enzyme family of protein tyrosine phosphatases (PTPs), are still lacking despite their undisputed involvement in human diseases. Efforts to pharmacologically modulate PTP activity have been frustrated by the conserved structure of the PTP catalytic core, providing a daunting problem with respect to target specificity. Over the years, however, many different protein interaction-based regulatory mechanisms that control PTP activity have been uncovered, providing alternative possibilities to control PTPs individually. Here, we review these regulatory principles, discuss existing biologics and proteinaceous compounds that affect PTP activity, and mention future opportunities to drug PTPs via these regulatory concepts. View Full-Text
Share & Cite This Article
Hendriks, W.; Bourgonje, A.; Leenders, W.; Pulido, R. Proteinaceous Regulators and Inhibitors of Protein Tyrosine Phosphatases. Molecules 2018, 23, 395.
Hendriks W, Bourgonje A, Leenders W, Pulido R. Proteinaceous Regulators and Inhibitors of Protein Tyrosine Phosphatases. Molecules. 2018; 23(2):395.Chicago/Turabian Style
Hendriks, Wiljan; Bourgonje, Annika; Leenders, William; Pulido, Rafael. 2018. "Proteinaceous Regulators and Inhibitors of Protein Tyrosine Phosphatases." Molecules 23, no. 2: 395.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.